Dosimetric Comparison of 192ir Sources Stereotactic Ablative Brachytherapy by Coplanar Template Assisted CT Guidance and Stereotactic Body Radiation Therapy in the Treatment of Early Stage Lung Cancer
H. Pang,X. Shi,X. Sun,J. Wu,S. Lin
DOI: https://doi.org/10.1016/j.ijrobp.2018.07.1952
2018-01-01
Abstract:This study aimed to assess the dosimetric differences between 192Ir sources stereotactic ablative brachytherapy (SABT) by coplanar template assisted CT guidance and stereotactic body radiation therapy (SBRT) in the treatment of early stage lung cancer. A total of 33 patients with stage I-II lung cancer for SABT were studied (Chinese Clinical Trials Register No.ChiCTR1800014541). Prescribed dose for GTV was 30 Gy in 1 fraction (D90% was 30Gy, BED was 120 Gy). A simulation plan was worked out prior to SABT, simulative applicators were constructed, and the quantity of applicators and their locations in the coplanar template were determined. It should be ensured that GTV could get the prescribed dose while the doses of OARs were kept as low as possible. When the SABT was actually performed, the location of simulative applicators in the coplanar template was taken as the actual location through which the applicators implant the tumor target area. Replan the patient's plans with SABT, GTV prescription doses (D95%) were 30 Gy /1fraction (fr), 46.86 Gy/3fr and 56.4 Gy/5fr respectively (all the BED was 120 Gy). For SBRT plans, CT images obtained at the SABT simulation planning were transferred to SBRT planning system, with GTV expanded by 0.5cm to become PGTV. PGTV prescription doses (D95%) were 30 Gy/1fr, 46.86 Gy/3fr and 56.4 Gy/5fr, and all the BED was 120Gy. Two out of 33 patients had mild pneumothorax and no hemothorax and infection occurred. There were no statistically significant differences between the tumor target coverage parameters of SABT and SBRT plans in 1, 3 and 5 fraction. Whereas the tumor target V150 for SABT and SBRT was 30.52±16.78% vs. 0±0%. Regarding lung in 1fr , mean dose, D1000cc, D1500cc, values were 2.25 Gy, 1.55 Gy, 0.63 Gy, respectively, for SABT, whereas those values were 3.49 Gy, 2.75 Gy, 1.23 Gy, respectively, for SBRT. For OARs, all dosimetry parameters in SABT were significantly lower than those in SBRT. Compared with SBRT in the treatment of early stage lung cancer, SABT by coplanar template assisted CT guidance can generate a comparable dose within tumor target, while the organs at risk (OARs) only receive a very low dose.